A US national randomized study to guide how best to reduce stigma when describing drug‐related impairment in practice and policy

Background and Aims Drug‐related impairment is persistently stigmatized delaying and preventing treatment engagement. To reduce stigma, various medical terms (e.g. ‘chronically relapsing brain disease’, ‘disorder’) have been promoted in diagnostic systems and among national health agencies, yet some...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Addiction (Abingdon, England) England), 2021-07, Vol.116 (7), p.1757-1767
Hauptverfasser:	Kelly, John F., Greene, M. Claire, Abry, Alexandra
Format:	Artikel
Sprache:	eng
Schlagworte:	Attribution Biomedicine Blame Brain Brain diseases Clinical trials Diagnostic systems Disease Drug development Drugs Human agency Life Sciences & Biomedicine Medical prognosis Medical terminology Medicalization Medicine Narcotics National nationally representative Opioids Optimism Psychiatry Public health randomized controlled study Research Report Research Reports Response rates Science & Technology Social exclusion Stigma stigma, discrimination Substance Abuse Terminology Threats Vignettes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!